A detailed history of Arnhold LLC transactions in Novartis Ag stock. As of the latest transaction made, Arnhold LLC holds 12,636 shares of NVS stock, worth $1.34 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
12,636
Previous 12,636 -0.0%
Holding current value
$1.34 Million
Previous $1.28 Million 4.16%
% of portfolio
0.13%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $240,090 - $278,430
-3,000 Reduced 19.19%
12,636 $1.16 Million
Q1 2022

May 10, 2022

BUY
$80.11 - $90.62 $240,330 - $271,860
3,000 Added 23.74%
15,636 $1.37 Million
Q4 2021

Feb 08, 2022

SELL
$79.7 - $88.13 $239,100 - $264,390
-3,000 Reduced 19.19%
12,636 $1.11 Million
Q1 2021

Apr 30, 2021

SELL
$83.5 - $98.47 $17,702 - $20,875
-212 Reduced 1.34%
15,636 $1.34 Million
Q1 2018

May 11, 2018

BUY
$70.39 - $84.15 $1.12 Million - $1.33 Million
15,848 New
15,848 $1.28 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Arnhold LLC Portfolio

Follow Arnhold LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arnhold LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arnhold LLC with notifications on news.